[Prevention of lactation with a new ergot derivative, CB-154. Comparison with ablacton].
D000328:Adult; D004338:Drug Combinations; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D009640:Norethindrone / Q000627:therapeutic use*; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors; D013739:Testosterone / Q000627:therapeutic use*
D004338:Drug Combinations; D004876:Ergot Alkaloids; D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D009640:Norethindrone
Prévention de la lactation par un nouveau dérivé de l'ergot CB-154. Etude comparative avec ablacton